Merck & Co., Inc.
BG ˙ BUL ˙ US58933Y1055
SecurityBG:6MK / Merck & Co., Inc.
InstitutionGeneral Partner, Inc.
Latest Disclosed Ownership8,686 shares
Latest Disclosed Value $ 1,044,839
General Partner, Inc. ownership in 6MK / Merck & Co., Inc.

On April 8, 2026 - General Partner, Inc. filed a 13F-HR form disclosing ownership of 8,686 shares of Merck & Co., Inc. (BG:6MK) valued at $1,044,839 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 6, 2026 disclosing 8,686 shares of Merck & Co., Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F Merck CL 58933Y105 8,686 0 0.00 1,045 14.22 0.4051
2026-01-06 2025-12-31 13F Merck CL 58933Y105 8,686 0 0.00 914 25.38 0.5184
2025-10-08 2025-09-30 13F Merck CL 58933Y105 8,686 0 0.00 729 6.11 0.4013
2025-07-07 2025-06-30 13F Merck CL 58933Y105 8,686 0 0.00 688 -11.81 0.4029
2025-04-04 2025-03-31 13F Merck CL 58933Y105 8,686 0 0.00 780 -9.84 0.5078
2025-01-03 2024-12-31 13F Merck CL 58933Y105 8,686 0 0.00 864 -12.37 0.5205
2024-10-02 2024-09-30 13F Merck CL 58933Y105 8,686 0 0.00 986 -8.28 0.6128
2024-07-05 2024-06-30 13F Merck CL 58933Y105 8,686 42 0.49 1,075 -5.70 0.6870
2024-04-01 2024-03-31 13F Merck CL 58933Y105 8,644 2,151 33.13 1,141 57.46 0.7165
2024-01-08 2023-12-31 13F Merck CL 58933Y105 6,493 0 0.00 725 7.90 0.6092
2023-10-10 2023-09-30 13F MERCK CL 58933Y105 6,493 0 0.00 671 -10.41 0.5990
2023-07-03 2023-06-30 13F MERCK CL 58933Y105 6,493 0 0.00 749 4.32 0.6245
2023-04-07 2023-03-31 13F MERCK CL 58933Y105 6,493 578 9.77 718 9.45 0.6313
2023-01-05 2022-12-31 13F MERCK CL 58933Y105 5,915 5,915 656 0.6037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.